Interview with Afshin Safavi (Founder & Chief Scientific Officer, BioAgilytix) on biomarker analysis in support of preclinical and clinical studies

Written by Cameron Low, Future Science Group

We sat down with Afshin Safavi (BioAgilytix) at the recent Reid Bioanalytical Forum and discussed the challenges faced when running biomarker studies, whether the use of biomarkers in preclinical and clinical studies will continue and more. Click the video above to watch the full interview.